Advancing the Understanding and Treatment of Heart Diseases


The EMAPs-Cardio project will contribute to the following impacts:

  • Verifiable progress in the application of Organ-on-Chip (OoC) technologies for in vitro research
  • Reduction of the number of clinical trials
  • Higher drug approval rate
  • Elimination of animal testing for cardiovascular drug screening
  • Lowering of barriers for application of OoC technology
  • Improved competitiveness and attractiveness of the European biomedical and healthcare sector
  • Increased investment to cardiovascular drug research and development
  • Strengthened collaboration between European SMEs and academia